News

Radiologists criticize Anthropic CEO’s recent comments about the specialty

Ben White, MD, believes Dario Amodei may have “set a new record on how quickly you can be wrong about how radiology works and how it’s been affected by AI so far.”

Radiology Partners’ AI business receives Breakthrough Device designation from FDA

The country’s largest imaging group announced the news March 5, with the decision applying to its Cognita Chest X-ray tool across multiple clinical indications.

FDA clears AI triage tool that detects acute infarcts on noncontrast CT scans

Unlike many stroke detection applications on the market, this model covers six vascular territories and mechanisms of infarct.

artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google

'Jack-of-all-trades' AI model outperforms numerous others in CT-related tasks

Unlike other artificial intelligence tools, Merlin was built with many tasks in mind, and researchers believe its capabilities could be further expanded—with some fine-tuning.

FTC seeks more time to settle insulin pricing lawsuit with remaining PBM defendants

The request to the court comes a month after the agency settled with Express Scripts, under the condition the company change its wholesale buying practices, pass on manufacturer rebates and support TrumpRx.gov. Now it's up to CVS Caremark and UnitedHealth’s Optum Rx to make deals of their own.

Black surgery technician reassigned over race settles discrimination lawsuit out of court

Clestina Lamai, the surgical technician, claimed in a lawsuit that Iowa Methodist Medical Center removed her from surgery at the request of a racist patient. The case was settled as a jury was set to deliver its verdict, local media reports.

Blood filtration company fined $5.7M, executive charged, for covering up patient deaths

The U.S. Department of Justice said ExThera cooperated with the investigation into a failure to file adverse event notices with the Food and Drug Administration after two cancer patients who used its blood filtration systems in Antigua died shortly after returning home. The California-based company’s former chief regulatory officer has agreed to plead guilty and could serve prison time.

Tenaya Therapeutics could earn up to $1.1B for new heart disease research

Tenaya Therapeutics and Alnylam Pharmaceuticals have agreed to collaborate on identifying potential new gene therapies for the treatment of cardiovascular disease. Tenaya will receive an upfront payment of $10 million, but stands to earn much more.

Farapulse Boston Scientific Pulsed Field Ablation PFA fda approval

Boston Scientific’s Farapulse PFA system receives expanded approval

The technology first gained CE mark approval for the treatment of paroxysmal AFib in 2021, when PFA was still brand new. Now, thanks to positive results from the ADVANTAGE AF clinical trial, it is approved for persistent AFib as well.

artificial intelligence AI policy washington capitol

Cardiology groups to Trump administration: AI still has a long way to go

Multiple cardiology societies responded to an HHS request for public feedback by outlining some of the current barriers to wider AI adoption. "It is essential that any policy frameworks must reaffirm that clinicians—not algorithms—remain at the center of patient care," ACC President Christopher Kramer, MD, said.

Lantheus receives tentative FDA approval for its radio-equivalent to Lutathera

Lantheus’ version of a radiopharmaceutical capable of targeting somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has been tentatively approved by the FDA.

After traversing the aortic cusp with an electrified wire and balloon inflation, a stent is positioned inside the noncoronary cusp and deployed. Immediately after, a transcatheter aortic valve is expanded, and the stent is crushed on the left ventricular outflow tract wall and annulus, while anchored to the aortic valve leaflet.

Cardiologists perform first TAVR of its kind by anchoring valve to crushed stent

The patient, 78, presented with severe AR and no signs of calcification. She was considered a poor choice for surgery or traditional TAVR due to multiple risks. That is where the new-look ATLAS technique came in.

Around the web

Radiology Business

Radiologists criticize Anthropic CEO’s recent comments about the specialty

Ben White, MD, believes Dario Amodei may have “set a new record on how quickly you can be wrong about how radiology works and how it’s been affected by AI so far.”